RxDoctor Payments Data

Jason Thompson, MD

Adult Reconstructive Orthopaedic Surgery · Corpus Christi, TXNPI 1326465576

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 78.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $14,568, 7.8 times the $1,870 reported in 2019.

$24,607in general payments, 2019–2025

Across 110 payments — averaging $223.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$19K
  • Integra Lifesciences Corporation$3K
  • Medinc Of Texas$2K
  • Davol Inc.$125
  • KCI USA, Inc.$124
  • Ferring Pharmaceuticals Inc.$76
  • plus $185 from 7 others

What the payments were for

  • Consulting fees$11,81348%
  • Travel & lodging$5,07221%
  • Food & beverage$5,80124%
  • Education$1,8708%
  • Other$510%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,607 in reported general payments places this provider in the 65th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$425,661
Medicare patients
562
Services billed
30,903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$27,840
Celecoxib638$10,711
Diclofenac Sodium665$8,396
Gabapentin646$7,457
Tramadol Hcl856$6,544
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen331$6,306
Cephalexin494$5,131
Oxycodone Hcl389$2,332
Doxycycline Hyclate59$2,108
Rifampin23$2,092
Cyclobenzaprine Hcl147$2,069
Vancomycin Hcl21$1,909
Methylprednisolone103$916
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim54$883
Acetaminophen-CodeineAcetaminophen With Codeine62$824

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →